Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Jakubowicz

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
European Journal of Gynaecological Oncology|May 23, 2018
Distant metastases from invasive lobular breast carcinoma classic type - treatment and prognosisP Skotnicki, B Sas-Korczynska, L Wohadlo, et al.
The Journal of Clinical Endocrinology and Metabolism|January 1, 1993
Effects of nitrendipine on glucose tolerance and serum insulin and dehydroepiandrosterone sulfate levels in insulin-resistant obese and hypertensive menN A Beer, D J Jakubowicz, R M Beer, et al.
The American Journal of the Medical Sciences|May 1, 1996
Dehydroepiandrosterone reduces plasma plasminogen activator inhibitor type 1 and tissue plasminogen activator antigen in menN A Beer, D J Jakubowicz, D W Matt, et al.
The Journal of Clinical Endocrinology and Metabolism|June 17, 1998
Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction systemJ E Nestler, D J Jakubowicz, A F de Vargas, et al.
The Journal of Clinical Endocrinology and Metabolism|January 13, 2004
Metformin therapy increases insulin-stimulated release of D-chiro-inositol-containing inositolphosphoglycan mediator in women with polycystic ovary syndromeJean-Patrice Baillargeon, Maria J Iuorno, Daniela J Jakubowicz, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|February 4, 2015
Macrophage-derived chemokine CCL22 and regulatory T cells in ovarian cancer patientsI Wertel, J Surówka, G Polak, et al.
The Journal of Clinical Endocrinology and Metabolism|February 7, 2004
Reduced serum glycodelin and insulin-like growth factor-binding protein-1 in women with polycystic ovary syndrome during first trimester of pregnancyDaniela J Jakubowicz, Paulina A Essah, Markku Seppälä, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|July 15, 2004
Effects of d-chiro-inositol in lean women with the polycystic ovary syndromeMaria J Iuorno, Daniela J Jakubowicz, Jean-Patrice Baillargeon, et al.
The Journal of Clinical Endocrinology and Metabolism|March 10, 2001
Insulin reduction with metformin increases luteal phase serum glycodelin and insulin-like growth factor-binding protein 1 concentrations and enhances uterine vascularity and blood flow in the polycystic ovary syndromeD J Jakubowicz, M Seppälä, S Jakubowicz, et al.
Breast Cancer Research and Treatment|August 18, 2014
Pathologic complete response to neoadjuvant cisplatin in BRCA1-positive breast cancer patientsT Byrski, T Huzarski, R Dent, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
European Journal of Gynaecological Oncology|May 23, 2018
Distant metastases from invasive lobular breast carcinoma classic type - treatment and prognosisP Skotnicki, B Sas-Korczynska, L Wohadlo, et al.
The Journal of Clinical Endocrinology and Metabolism|January 1, 1993
Effects of nitrendipine on glucose tolerance and serum insulin and dehydroepiandrosterone sulfate levels in insulin-resistant obese and hypertensive menN A Beer, D J Jakubowicz, R M Beer, et al.
The American Journal of the Medical Sciences|May 1, 1996
Dehydroepiandrosterone reduces plasma plasminogen activator inhibitor type 1 and tissue plasminogen activator antigen in menN A Beer, D J Jakubowicz, D W Matt, et al.
The Journal of Clinical Endocrinology and Metabolism|June 17, 1998
Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction systemJ E Nestler, D J Jakubowicz, A F de Vargas, et al.
The Journal of Clinical Endocrinology and Metabolism|January 13, 2004
Metformin therapy increases insulin-stimulated release of D-chiro-inositol-containing inositolphosphoglycan mediator in women with polycystic ovary syndromeJean-Patrice Baillargeon, Maria J Iuorno, Daniela J Jakubowicz, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|February 4, 2015
Macrophage-derived chemokine CCL22 and regulatory T cells in ovarian cancer patientsI Wertel, J Surówka, G Polak, et al.
The Journal of Clinical Endocrinology and Metabolism|February 7, 2004
Reduced serum glycodelin and insulin-like growth factor-binding protein-1 in women with polycystic ovary syndrome during first trimester of pregnancyDaniela J Jakubowicz, Paulina A Essah, Markku Seppälä, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|July 15, 2004
Effects of d-chiro-inositol in lean women with the polycystic ovary syndromeMaria J Iuorno, Daniela J Jakubowicz, Jean-Patrice Baillargeon, et al.
The Journal of Clinical Endocrinology and Metabolism|March 10, 2001
Insulin reduction with metformin increases luteal phase serum glycodelin and insulin-like growth factor-binding protein 1 concentrations and enhances uterine vascularity and blood flow in the polycystic ovary syndromeD J Jakubowicz, M Seppälä, S Jakubowicz, et al.
Breast Cancer Research and Treatment|August 18, 2014
Pathologic complete response to neoadjuvant cisplatin in BRCA1-positive breast cancer patientsT Byrski, T Huzarski, R Dent, et al.
Pageof 5